跳至主要内容
临床试验/CTRI/2021/03/032149
CTRI/2021/03/032149已完成不适用

An Open-label, Single Centre Study, to Determine the Safety and Efficacy of Body Lotion and Body Wash in Adult Female Subjects with Mild To Moderate Eczema.

Wipro Manufacturing Services Sdn Bhd1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2021年3月30日最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
1
主要终点
1.Selection of unaffected and affected test sites by the dermatologist using instrument evaluations.

研究概览

简要总结

The objective of this study is to evaluate the efficacy of body lotionon Eczema symptoms improvement infemale subjects with mild to moderate eczema in a 4-week home use test.

For this study, compatibility means that the Test product does notworsen the skin condition, determined by an assessment of the lesional andnon-lesional skin sites, also cutaneous tolerance of body lotion on Eczema skinwill be assessed.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Open Label

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
Female

入选标准

  • Age: 18 to 65 years (both inclusive) old healthy, non-pregnant, and non-lactating female at the time of consent.
  • Females who have childbearing potential should have a negative urine pregnancy test at the time of the screening visit.
  • Mild to Moderate Eczema determined by Eczema Area and Severity Index (EASI) score on screening visit.
  • Subjects with at least two active lesions on feet/face/hands or any part of the body.
  • Subjects have only a few or no pigmentation on the selected test site.
  • The subject’s in general good health as determined by Investigator based on medical history.
  • Subjects must agree to refrain from shower/bath or generally wet their skin within 3 hours before scheduled study visits.
  • Subjects must be able to understand and provide written informed consent to participate in the study.
  • Subjects should be willing and able to follow the study protocol to participate in the study.

排除标准

  • 未提供

结局指标

主要结局

1.Selection of unaffected and affected test sites by the dermatologist using instrument evaluations.

时间窗: 1.On Day 01 before application and on Day 14 and Day 28 after product usage | 2.On Day 01 before application and Day 14 and Day 28 after product usage

2.Calculation of eczema area by dermatologist using Eczema Area and Severity Index (EASI).

时间窗: 1.On Day 01 before application and on Day 14 and Day 28 after product usage | 2.On Day 01 before application and Day 14 and Day 28 after product usage

次要结局

  • 1.cutaneous tolerance/ local irritation i.e. Erythema, Oedema, Dryness, Flaking, Scaling, Itching, Peeling, Pigmentation for body wash and body lotion(2.Global Assessment Scale (IGA) for body wash and body lotion)

研究者

申办方类型
Other [Personal Care Industry]

研究点 (1)

Loading locations...

相似试验